Grown Rogue International (GRIN) AI Stock Analysis

• Market Cap: C$112.31M
• Dividend Yield: N/A
• Average Volume (3M): 71.83K
• Price to Earnings (P/E): 10.0
• Beta (1Y): 0.87
• Revenue Growth: -18.30%
• EPS Growth: N/A
• Country: CA
• Employees: 204
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.01
• Shares Outstanding: 249,581,070
• 10 Day Avg. Volume: 38,149
• 30 Day Avg. Volume: 71,828
• PEG Ratio: -0.11
• Price to Book (P/B): 3.50
• Price to Sales (P/S): 4.85
• P/FCF Ratio: 132.49
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 50 Neutral
• Price Target: C$0.44 ▼(-26.27% Downside)
• Action: Reiterated Date: 02/26/26
• Date: Action: Reiterated 02/26/26

The score is held back primarily by weak financial performance (declining revenue, negative profitability, and deteriorating free cash flow) and bearish technicals. These are partially offset by a reasonable valuation (P/E ~13) and a more constructive earnings-call outlook centered on cost reductions, liquidity, and expansion progress despite ongoing pricing pressure.

Positive Factors

Low production costs & rising yields

Sustained reductions in per‑pound production costs and a 20% yield improvement materially lower the company’s breakeven. Over months, this supports margin resilience versus pricing cycles, enables flexible pricing strategies, and increases free cash generation potential as volumes scale.

Stronger liquidity and committed credit

A larger low‑cost credit facility plus a >$13M cash balance improves financial flexibility to fund expansion, absorb operating seasonality, and execute turnarounds without immediate equity raises. This reduces short‑term refinancing risk and supports multi‑quarter execution plans.

Geographic expansion driving pro forma growth

Entry into New Jersey and planned Minnesota expansion diversify sales beyond core markets and have already boosted pro‑forma top line. Over 2–6 months, successful market rollouts can scale revenue, spread fixed costs, and reduce reliance on struggling legacy markets.

Negative Factors

Declining revenue trend

A contracting top line erodes operating leverage and limits reinvestment capacity. Persisting revenue declines over multiple quarters make it harder to recover fixed costs, prolong negative profitability, and constrain cash flow available for expansion or debt servicing.

Negative net and EBIT margins

Healthy gross margin but negative operating and net margins indicate structural cost or SG&A pressures and an inability to convert production economics into profitability. Without sustained margin improvement, returns on equity and cash generation will remain impaired.

Market pricing pressure and NJ ramp issues

Persistent low pricing in core states reduces revenue per unit while New Jersey’s early low yields and high ramp costs raise unit cost during scale‑up. Combined, these structural market and execution issues slow margin recovery and magnify execution risk during expansion.

Grown Rogue International Business Overview & Revenue Model

Company Description

Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States. It offers flower products, such as indicas, sativas, and hybrids; and edibles, vape cartridges, pre-rolls, or concentrates. The company sells its products through dispensaries. Grown Rogue International Inc. is headquartered in Medford, Oregon.

How the Company Makes Money

Grown Rogue International generates revenue primarily through the sale of its cannabis products to dispensaries and consumers in legal markets. The company has established key revenue streams from its cultivation operations, which involve growing and harvesting cannabis plants for direct sale. Additionally, Grown Rogue engages in wholesale distribution, allowing it to supply larger volumes of product to retailers. The company also benefits from strategic partnerships with other cannabis businesses and distributors, enhancing its market reach and operational efficiency. Marketing initiatives and brand development further contribute to customer loyalty and repeat sales, bolstering overall revenue.

Grown Rogue International Financial Statement Overview

Summary

Financials are pressured by contracting revenue (-6.85% TTM) and ongoing profitability issues (negative net and EBIT margins). The balance sheet is moderately stable (debt-to-equity 0.58), but negative ROE and sharply declining free cash flow growth (-54.47%) point to weak returns and liquidity strain.

Income Statement

Grown Rogue International's income statement reveals mixed performance. The TTM data shows a decline in revenue growth rate by 6.85%, indicating a contraction in sales. The gross profit margin is stable at around 50%, but the net profit margin is negative, reflecting ongoing profitability challenges. The EBIT margin is also negative, suggesting operational inefficiencies. However, the EBITDA margin is positive, indicating some level of operational cash flow generation.

Balance Sheet

The balance sheet shows moderate financial stability. The debt-to-equity ratio is 0.58, indicating a balanced approach to leveraging. However, the return on equity is negative, reflecting challenges in generating returns for shareholders. The equity ratio is reasonable, suggesting a fair proportion of equity financing relative to total assets.

Cash Flow

Cash flow analysis indicates potential liquidity concerns. The free cash flow growth rate is negative at -54.47%, highlighting a decline in cash available for reinvestment. The operating cash flow to net income ratio is below 1, suggesting limited cash generation relative to net income. The free cash flow to net income ratio is positive, indicating some cash flow coverage of net income.

Breakdown	Sep 2025	Mar 2025	Oct 2023	Jan 2023	Oct 2021
Income Statement
Total Revenue	22.15M	27.02M	21.83M	17.76M	9.38M
Gross Profit	11.03M	13.44M	14.22M	8.12M	6.10M
EBITDA	10.21M	-3.66M	3.44M	3.41M	2.55M
Net Income	6.35M	-11.30M	-533.04K	447.46K	-1.01M
Balance Sheet
Total Assets	55.90M	43.32M	30.16M	16.37M	14.21M
Cash, Cash Equivalents and Short-Term Investments	13.09M	4.68M	8.86M	1.58M	1.11M
Total Debt	17.37M	8.39M	6.72M	4.91M	4.57M
Total Liabilities	23.66M	27.41M	17.61M	7.43M	7.09M
Stockholders Equity	30.67M	14.55M	11.56M	6.93M	5.09M
Cash Flow
Free Cash Flow	811.46K	5.39M	4.27M	892.89K	-2.29M
Operating Cash Flow	2.54M	7.12M	5.73M	2.00M	-238.46K
Investing Cash Flow	-4.78M	-12.20M	-2.89M	-1.11M	-2.73M
Financing Cash Flow	11.22M	2.95M	4.43M	-422.54K	3.86M

Grown Rogue International Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.59
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GRIN, the sentiment is Negative. The current price of 0.59 is above the 20-day moving average (MA) of 0.51, above the 50-day MA of 0.55, and above the 200-day MA of 0.54, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 31.68 is Neutral, neither overbought nor oversold. The STOCH value of 19.71 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GRIN.

Grown Rogue International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
XLY	67 Neutral	C$170.88M	2.37	31.46%	―	27.38%	―
LOVE	67 Neutral	C$180.77M	36.96	13.39%	―	30.64%	101.12%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GRIN	50 Neutral	C$112.31M	9.97	15.32%	―	-18.30%	―
JUSH	47 Neutral	C$121.95M	-2.14	―	―	3.17%	-24.07%
CBST	37 Underperform	C$227.80M	-0.97	―	―	-26.73%	-32.33%

Grown Rogue International Corporate Events

Grown Rogue’s New Jersey Affiliate Marks First Year with Expansion Plans

Grown Rogue International’s New Jersey affiliate, ABCO Garden State, celebrates its first year of sales, achieving significant production and sales milestones. The company has seen increased demand for its Yeti value brand and is currently expanding its production capacity with Phase 2 construction, aiming to deepen its presence in the New Jersey market while maintaining a disciplined approach to capital deployment.

The most recent analyst rating on (TSE:GRIN) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Grown Rogue International stock, see the TSE:GRIN Stock Forecast page.

Grown Rogue Expands into Minnesota with New Cultivation Facility

Grown Rogue International Inc. has secured a long-term lease for a cannabis cultivation facility in Fridley, Minnesota, marking a significant step in its expansion into the Minnesota market. The facility, which has received local approval for cannabis cultivation, will undergo phased construction beginning in 2026, with the first products expected in early 2027. This strategic move positions Grown Rogue to capitalize on the growing demand for cannabis in Minnesota, with the potential to expand its flower canopy to the maximum allowed size, thereby enhancing its market presence and operational scale.

The most recent analyst rating on (TSE:GRIN) stock is a Hold with a C$0.50 price target. To see the full list of analyst forecasts on Grown Rogue International stock, see the TSE:GRIN Stock Forecast page.